Wednesday November 27, (BUSINESS WIRE)-- New research on HTS Biosystems' and Applied Biosystems' proprietary biomolecular kinetic analysis technology will be presented at IBC Life Sciences' 13th Annual International Conference on Antibody Engineering (December 1-4, 2002). This next-generation microarray-based SPR (surface plasmon resonance) system is designed to help researchers profile and characterize biomolecular interactions in a parallel format, while decreasing costs associated with this productive type of quantitative analysis.
Highlights:
* Early access users of the technology, the University of Utah and Dyax Corp., will present their preliminary utility experience with the system.
* Demonstrations of the technology's user interface will be offered at the Applied Biosystems booth at the conference.
Why: - The Antibody Engineering Meeting will enable HTS Biosystems and Applied Biosystems to showcase their progress in the development of advanced, label-free SPR array technology designed to accelerate drug discovery R&D with higher throughput, content-rich biomolecular binding characterization screening.
Where: Paradise Point Resort
1404 Vacation Road
San Diego, CA 92109
When: The oral research presentations include:
* Sunday, December 1, 1:40 p.m. (PST): Affinity Biosensing to the nth Degree (Dr. David Myszka, Center for Biomolecular Interaction Analysis, University of Utah)
* Monday, December 2, 4:30 p.m. (PST): A Microarray-Based Surface Plasmon Resonance Method For the Rapid Determination of Phage Display Derived Human Antibody Dissociation Constants (Dr. Dan Sexton, Investigator, Dyax Corporation)
Data from the abstracts are embargoed to the
press until after each presentation. For more
information, or to obtain a copy of the abstract,
please visit:
lifesciencesinfo.com
About HTS HTS Biosystems, Inc. is a privately held Biosystems: biotechnology company specializing in high-throughput bioanalytical systems for the rapidly growing field of proteomics. HTS Biosystems offers a unique portfolio of innovative technologies that support all phases of proteomics, from discovery to development of therapeutic and diagnostic products. The company's technology platform - the Proteomatrix(TM) Solution - streamlines the discovery process and captures fixed costs for more effective use of protein data in target screening, validation, and discovery efforts. Collaborations with key industry partners, such as Applied Biosystems, Dyax Corporation, Mitsubishi Chemical Corporation, and Molsoft LLC have driven the development of the company's technologies and related systems, including the joint HTS Biosystems-Applied Biosystems next-generation SPR array technology platform, the CHEMI FLEX(TM) System, and the PHASE FLEX(TM) System for target discovery, screening and validation. HTS Biosystems' operations are located in Hopkinton, MA. For more information, visit www.htsbiosystems.com |
